e-ISSN 1309-2545      ISSN 1301-062X
TR    ENG
 

Download Current Issue.

Volume : 28 Issue : 2 Year : 2022

Current Issue Archive Popular Articles Ahead of Print Submit Your Article Login Copyright Transfer Form
Turkish Journal of Neurology Indexed By
  THE USE OF APOMORPHINE IN PARKINSON'S DISEASE [Turk J Neurol]
Turk J Neurol. 2001; 7(1): 117-126

THE USE OF APOMORPHINE IN PARKINSON'S DISEASE

Haşmet A. HANAĞASI1, Gülüstü KAPTANOĞLU2, Murat EMRE3
1İstanbul Tıp Fakültesi Nöroloji Anabilim Dalı Davranış Nörolojisi ve Hareket Bozuklukları Birimi
2Cognitive Neurology and Alzheimer's Disease Resarch Center Northwestern University, Chicago
3İstanbul Tıp Fakültesi Nöroloji Anabilim Dalı Davranıı Nörolojisi ve Hareket Bozuklukları Birimi

Apomorphine, a D 1 and D2 receptor agonist was the first dopaminergic drug everused to treat symptoms of Parkinson's disease (PD). In the last decade subcutaneous infusions of apomorphine have been shown to improve motor complications of late stage PD. in this article treatment with the apomorphine in PD and its role as a diagnostic tool far assessing dopaminergic responsiveness are reviewed.

Keywords: Parkinson's disease, motor fluctuations, apomorphine


Haşmet A. HANAĞASI, Gülüstü KAPTANOĞLU, Murat EMRE. THE USE OF APOMORPHINE IN PARKINSON'S DISEASE. Turk J Neurol. 2001; 7(1): 117-126

Corresponding Author: Haşmet A. HANAĞASI


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
© Copyright 2022 Turkish Journal of Neurology
Home        |        Contact
LookUs & OnlineMakale